Kim Statham Ringen on the Importance of Meeting Other Survivors

Article

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.

“I know all the statistics — the odds are against me,” Ringen says. “You don’t actually obtain hope until you meet another individual who’s pretty much just like you — same stage, same treatment options — and they’re out four years, five years, six years, seven years.”

Related Videos
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE